Immediate Impact

57 standout
Sub-graph 1 of 25

Citing Papers

Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline: 2024 Amendment
2024 Standout
European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update
2024 Standout
1 intermediate paper

Works of Y Ono being referenced

Multivariate evaluation of factors affecting recurrence, progression, and survival in patients with superficial bladder cancer treated with intravesical bacillus Calmette-Guérin (Tokyo 172 strain) therapy: Significance of concomitant carcinoma in situ
2002

Author Peers

Author Last Decade Papers Cites
Y Ono 229 51 104 63 29 346
M. Bakkaloĝlu 96 86 168 101 32 311
Sheng‐Hsien Chu 210 13 206 65 35 404
Johan Poulsen 227 6 128 33 30 405
Ronney Abaza 198 3 177 22 24 326
S. Giancane 118 53 216 12 22 393
Jennifer Roem 164 12 21 51 30 351
Yves Caumartin 178 132 100 67 26 368
Demosthenes D. Cokkinos 140 12 121 27 23 393
Seung Hwan Song 111 105 38 23 31 347
Yang Wu 184 4 87 67 31 326

All Works

Loading papers...

Rankless by CCL
2026